DURECT Corp (NASDAQ:DRRX)
CAPS Rating:
The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.
RSS Headlines
Fool UK
Recs
Options Predictor Rank #48 on 9/11/11. P/C Ratio 0.186 and Call Sizzle 3.817.